Detalhe da pesquisa
1.
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
Lancet Oncol
; 24(3): 252-261, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858722
2.
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Lancet Oncol
; 23(1): 125-137, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895479
3.
Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.
Leuk Lymphoma
; 56(5): 1308-14, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25204374
4.
Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report.
Eur J Cancer
; 48(11): 1700-6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22093944